Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00984997 · ClinicalTrials.gov registry record · Phase 2

Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors

A Phase 2 study of Lung Cancer, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
Phase 2
Development phase
38
Enrollment target
1
Study location

NCT00984997: Completed Phase 2 study of Lung Cancer, sponsored by M.D. Anderson Cancer Center.

NCT00984997 is a Phase 2 study of Lung Cancer that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 38 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00984997, a Phase 2 study of Lung Cancer, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
Phase 2
Development phase
38 participants
Enrollment target
1
Study location

Study Summary

1. To determine the outcome of patients with potentially resectable superior sulcus tumors of non-small cell histology treated by surgery followed by accelerated radiation therapy and chemotherapy. 2. To evaluate toxicity, the initial local-regional control rate, sites of and time to local and distant failures.

Conditions Studied

Lung Cancer

Interventions

  • DRUG Cisplatin
  • DRUG Etoposide
  • PROCEDURE Surgery
  • RADIATION Prophylactic Cranial Irradiation
  • RADIATION Chest Irradiation

Study Locations (1)

Texas

  • University of Texas MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 1993-10
Est. Completion 2015-06
Phase Phase 2

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00984997

The ClinicalTrials.gov registry entry for NCT00984997 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (96% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 5 interventions - of which Cisplatin is the first listed.

NCT00984997 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00984997 about?

NCT00984997 is a clinical study titled "Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors". 1. To determine the outcome of patients with potentially resectable superior sulcus tumors of non-small cell histology treated by surgery followed by accelerated radiation therapy and chemotherapy. 2. To evaluate toxicity, the initial local-regional control rate, sites of and time to local and dista...

What is the current status of trial NCT00984997?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 38 participants. The study started on 1993-10. Estimated completion is 2015-06.

What conditions does trial NCT00984997 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT00984997?

The interventions under investigation include: Cisplatin (DRUG), Etoposide (DRUG), Surgery (PROCEDURE), Prophylactic Cranial Irradiation (RADIATION), Chest Irradiation (RADIATION).

Who is sponsoring clinical trial NCT00984997?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00984997 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lung Cancer

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.